She has more than 25 years of experience in investor relations and corporate communications. She last worked as vice president of investor relations at San Diego-based biotech company Illumina, according to a May 10 announcement. At NuVasive, she will head the company’s investor relations program.
Ms. Cunningham received her bachelor’s degree in business administration at the University of Michigan in Ann Arbor and completed graduate programs in investor relations and executive leadership at Stanford (Calif.) University.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.